Search - tctmd.com

Displaying 21 - 28 of 28

Sort: Relevancy | Date

Presentation TCT 2023

TCT 990: Left Atrial Veno-Arterial Extra-Corporeal Membrane Oxygenation in Cardiogenic Shock and Cardiorenal Syndrome as a Bridge to Combined Heart and Kidney Transplantation

Presenter: Richard Cheng

October 24, 2023

News Features

Myriad Novel Devices Aim to Boost Decongestion in Acute HF

Todd Neale

April 10, 2023

Presentation THT 2023

Safety and Performance of the Aortix™ Device in Patients With Decompensated Heart Failure and Cardiorenal Syndrome

Presenter: Jennifer Cowger

March 21, 2023

Presentation THT 2023

The Nephronyx Perfuser: A Novel Device That Targets Increased Renal Venous Pressure in Patient With Cardiorenal Syndrome

Presenter: Oren Caspi

March 21, 2023

Presentation Miami Valves 2023

Cardiorenal Syndrome and Renal Protection: Fact Vs Fiction

Presenter: Mrudula R. Munagala

February 02, 2023

News Conference News AHA 2022

TRANSFORM-HF: Torsemide No Better Than Furosemide for Hospitalized HF

Todd Neale

November 05, 2022

News Industry News

Procyrion Announces Successful First-in-Human Cases in Cardiorenal Syndrome (CRS) Patients with Aortix™ Percutaneous Mechanical Circulatory Support Device

May 25, 2021

News Daily News

Renal Function Gains Seen in CKD Patients After TAVR

L.A. McKeown

September 15, 2020

Advertisement

TCT 990: Left Atrial Veno-Arterial Extra-Corporeal Membrane Oxygenation in Cardiogenic Shock and Cardiorenal Syndrome as a Bridge to Combined Heart and Kidney Transplantation

Myriad Novel Devices Aim to Boost Decongestion in Acute HF

Safety and Performance of the Aortix™ Device in Patients With Decompensated Heart Failure and Cardiorenal Syndrome

The Nephronyx Perfuser: A Novel Device That Targets Increased Renal Venous Pressure in Patient With Cardiorenal Syndrome

Cardiorenal Syndrome and Renal Protection: Fact Vs Fiction

TRANSFORM-HF: Torsemide No Better Than Furosemide for Hospitalized HF

Procyrion Announces Successful First-in-Human Cases in Cardiorenal Syndrome (CRS) Patients with Aortix™ Percutaneous Mechanical Circulatory Support Device

Renal Function Gains Seen in CKD Patients After TAVR

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content